Cyclerion Therapeutics, Inc. - Common Stock, no par value (CYCN)

Historical Holders from Q1 2023 to Q3 2025

Symbol
CYCN on Nasdaq
Type / Class
Equity / Common Stock, no par value
Shares outstanding
3.37M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
259K
Holdings value
$595K
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
17
Number of buys
5
Number of sells
-6
Average Value change %
-0.01%
Average buys %
+0%
Average sells %
-0.013%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cyclerion Therapeutics, Inc. - Common Stock, no par value (CYCN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Hecht Peter M 27.9% $2.63M 1.03M Peter M. Hecht 25 Mar 2025
J. WOOD CAPITAL ADVISORS LLC 5.4% $496K 182K J. Wood Capital Advisors LLC 25 Mar 2025
TYNDALL CAPITAL PARTNERS L P 4.8% -6% $405K -$25K 155K -5.82% Tyndall Capital Partners, L.P. 30 Jun 2025
American Endowment Foundation 4.91% $341K 133K American Endowment Foundation 31 Dec 2024
FMR LLC 0.2% $12.1K 4.74K FMR LLC 31 Dec 2024

Institutional Holders of Cyclerion Therapeutics, Inc. - Common Stock, no par value (CYCN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 259K $595K -$334K $2.30 17
2025 Q2 363K $1.06M -$30.8K $2.91 17
2025 Q1 373K $932K -$29.3K $2.50 18
2024 Q4 382K $1.23M -$1.79M $3.22 18
2024 Q3 1.04M $2.7M -$289K $2.59 15
2024 Q2 1.05M $2.41M -$42.7K $2.30 17
2024 Q1 1.07M $3.42M +$2.57K $3.20 15
2023 Q4 1.07M $3.58M -$8.23K $3.35 15
2023 Q3 1.07M $3.66M +$244K $3.42 19
2023 Q2 995K $4.1M +$4.1M $4.12 19
2023 Q1 10 $4.00 +$4.00 $0.40 1